Login to Your Account



VaxGen, Feds Settle Anthrax Dispute; $11M Payment Due

By Randall Osborne


Monday, April 9, 2007
Troubled VaxGen Inc. traded up slightly on word that $11 million is coming from the feds after the anthrax vaccine was cancelled, but Thursday's conference call updating investors might have done little to quell concerns about the future. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription